S-glutathionylation and S-nitrosylation in mitochondria: Focus on homeostasis and neurodegenerative diseases

S Vrettou, B Wirth - International Journal of Molecular Sciences, 2022 - mdpi.com
Redox post-translational modifications are derived from fluctuations in the redox potential
and modulate protein function, localization, activity and structure. Amongst the oxidative …

Glutathione: an old and small molecule with great functions and new applications in the brain and in Alzheimer's disease

M Haddad, V Hervé, MR Ben Khedher… - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Glutathione (GSH) represents the most abundant and the main antioxidant in
the body with important functions in the brain related to Alzheimer's disease (AD). Recent …

Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model

C Zhang, RA Rissman, J Feng - Journal of Alzheimer's …, 2015 - content.iospress.com
Mitochondrial impairment as evidenced by decline in adenosine 5′-triphosphate (ATP) is
associated with oxidative stress in Alzheimer's disease neuropathology and suggests that …

Glutathionylation: a regulatory role of glutathione in physiological processes

K Dominko, D Đikić - Arhiv za higijenu rada i toksikologiju, 2018 - hrcak.srce.hr
Sažetak Glutathione (γ-glutamyl-cysteinyl-glycine) is an intracellular thiol molecule and a
potent antioxidant that participates in the toxic metabolism phase II biotransformation of …

Detection and quantification of 8‐hydroxy‐2′‐deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis

C Zhang, G Nestorova, RA Rissman, J Feng - Electrophoresis, 2013 - Wiley Online Library
8‐Hydroxy‐2′‐deoxyguanosine (8‐OHdG) is one of the major forms of oxidative DNA
damage, and is commonly analyzed as an excellent marker of DNA lesions. The purpose of …

The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease

RR Dyer, KI Ford, RAS Robinson - Methods in enzymology, 2019 - Elsevier
Alzheimer's disease (AD) is a debilitating dementia with complex pathophysiological
alterations including modifications to endogenous cysteine. S-nitrosylation (SNO) is a well …

Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases

L Gu, RAS Robinson - PROTEOMICS–Clinical Applications, 2016 - Wiley Online Library
Cysteine is a highly reactive amino acid and is subject to a variety of reversible post‐
translational modifications (PTMs), including nitrosylation, glutathionylation, palmitoylation …

Reversible redox modifications in the microglial proteome challenged by beta amyloid

V Correani, L Di Francesco, I Cera, G Mignogna… - Molecular …, 2015 - pubs.rsc.org
Microglia are resident macrophages in the central nervous system, whose participation
against exogenous injuries and infections is mainly marked by an immediate release of …

Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice

C Zhang, RA Rissman - PLoS One, 2017 - journals.plos.org
Increased production of hydroxyl radical is the main source of oxidative damage in
mammalian DNA that accumulates in Alzheimer's disease (AD). Reactive oxygen species …

Glutaredoxin1 protects neuronal cells from copper-induced toxicity

MA Cater, S Materia, Z Xiao, K Wolyniec, SM Ackland… - Biometals, 2014 - Springer
Abstract Glutaredoxin1 (GRX1) is a glutathione (GSH)-dependent thiol oxidoreductase. The
GRX1/GSH system is important for the protection of proteins from oxidative damage and in …